Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established robust manufacturing units focusing on this important antiviral medicine . Identifying the absolute top manufacturers can be challenging due t